Quretech Bio Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$25M
- Investors
-
11
Quretech Bio General Information
Description
Developer of antibacterial agents designed for combating infectious diseases and addressing antibiotic resistance. The company's platform focuses on creating a new class of small molecules with bactericidal effects on Gram-positive bacteria, including drug-resistant strains, featuring a novel mechanism of action, no cross-resistance, and activity against nondividing bacteria, enabling the healthcare market to access innovative methods for treating serious infections.
Contact Information
Website
www.quretech.comCorporate Office
- Tvistevägen 48
- 907 36 Umeå
- Sweden
Corporate Office
- Tvistevägen 48
- 907 36 Umeå
- Sweden
Quretech Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Grant | 23-Dec-2025 | $25M | Completed | Product Development | ||
| 7. Later Stage VC | 26-Oct-2020 | Completed | Product Development | |||
| 6. Grant | 21-Apr-2020 | Completed | Product Development | |||
| 5. Grant | 04-Dec-2019 | Completed | Product Development | |||
| 4. Grant | 21-Dec-2018 | Completed | Product Development | |||
| 3. Later Stage VC | 02-Oct-2018 | Completed | Product Development | |||
| 2. Accelerator/Incubator | 07-Apr-2016 | $194K | $194K | Completed | Product Development | |
| 1. Grant | 01-Jan-2014 | $5.04M | Completed | Product Development |
Quretech Bio Patents
Quretech Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022043537-A1 | Thiazine compounds for use in the diagnosis, prevention and/or treatment of a disease and/or disorder involving amyloid | Inactive | 28-Aug-2020 | ||
| EP-4146659-A1 | Ring-fused 2-pyridone compounds, methods for preparation thereof and their use in the treatment and/or prevention of a disease involving gram-positive bacteria | Active | 08-May-2020 | ||
| EP-4146659-B1 | Ring-fused 2-pyridone compounds, methods for preparation thereof and their use in the treatment and/or prevention of a disease involving gram-positive bacteria | Active | 08-May-2020 | ||
| ES-3017588-T3 | Ring-fused 2-pyridone compounds, methods for preparation thereof and their use in the treatment and/or prevention of a disease involving gram-positive bacteria | Active | 08-May-2020 | ||
| US-12503476-B2 | Ring-fused 2-pyridone compounds, methods for preparation thereof and their use in the treatment and/or prevention of a disease involving gram-positive bacteria | Active | 08-May-2020 | C07D513/04 |
Quretech Bio Signals
Quretech Bio Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| United States Patent and Trademark Office | Government | |||
| Nascent Invest | Venture Capital | Minority | ||
| The Kempe Foundations | Limited Partner | Minority | ||
| SWElife | Government | |||
| Erling Persson Family Foundation | Limited Partner |
Quretech Bio FAQs
-
When was Quretech Bio founded?
Quretech Bio was founded in 2010.
-
Where is Quretech Bio headquartered?
Quretech Bio is headquartered in Umeå, Sweden.
-
What is the size of Quretech Bio?
Quretech Bio has 8 total employees.
-
What industry is Quretech Bio in?
Quretech Bio’s primary industry is Drug Delivery.
-
Is Quretech Bio a private or public company?
Quretech Bio is a Private company.
-
What is Quretech Bio’s current revenue?
The current revenue for Quretech Bio is .
-
How much funding has Quretech Bio raised over time?
Quretech Bio has raised $1.82M.
-
Who are Quretech Bio’s investors?
United States Patent and Trademark Office, Nascent Invest, The Kempe Foundations, SWElife, and Erling Persson Family Foundation are 5 of 11 investors who have invested in Quretech Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process